-
141
Midregion PTHrP and Human Breast Cancer Cells
Published 2010-01-01“…The midregion PTHrP domain (38-94)-amide was found to restrain growth and invasion in vitro of some breast cancer cell lines, causing striking toxicity and accelerating death; the most responsive being MDA-MB231, whose tumorigenesis was also attenuated in vivo. In addition, midregion PTHrP appears to be imported in the nucleoplasm of cultured MDA-MB231 cells and in vitro, it can bind chromatin of metaphase spread preparations and also an isolated 20-mer oligonucleotide, thereby appearing endowed with a putative transcription factor–like DNA-binding ability. …”
Get full text
Article -
142
Molecular Imaging of Hypoxia-Inducible Factor 1α and von Hippel-Lindau Interaction in Mice
Published 2008-05-01“…Tumor hypoxia plays a crucial role in tumorigenesis. Under hypoxia, hypoxia-inducible factor 1α (HIF-1α) regulates activation of genes promoting malignant progression. …”
Get full text
Article -
143
Belzutifan for the treatment of renal cell carcinoma
Published 2025-02-01“…Most clear cell renal cell carcinoma (ccRCC) tumors are associated with VHL deletion or inactivation resulting in HIF-2α overexpression that represents a key contributor to tumorigenesis, thereby making belzutifan a uniquely optimal drug for targeting ccRCC. …”
Get full text
Article -
144
Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium
Published 2016-01-01“…This review encompasses the key immune checkpoints that have been found to play a role in tumorigenesis and, more specifically, gliomagenesis. …”
Get full text
Article -
145
Synchronous melanomas: one on tattoo and one on healthy skin
Published 2025-02-01“…Malignant melanoma cases arising from tattoos have been increasingly described; however, there is no clear relationship between this practice and tumorigenesis. We present a case of two synchronous melanomas (one located on a decorative tattoo) and update the literature. …”
Get full text
Article -
146
LARP3 inhibits the apoptosis of hepatocellular carcinoma via the ROS/PI3K/c-Fos axis.
Published 2025-01-01“…Finally, through biological means such as RNA sequencing, flow cytometry, western blotting, and the construction of a subcutaneous tumorigenesis model in nude mice, we concluded that inhibition of HCC apoptosis by LARP3 is related to LARP3 negatively regulating ROS level and inhibiting the PI3K/c-Fos/apoptosis axis. …”
Get full text
Article -
147
RNA Splicing: A New Player in the DNA Damage Response
Published 2013-01-01“…It is widely accepted that tumorigenesis is a multistep process characterized by the sequential accumulation of genetic alterations. …”
Get full text
Article -
148
KLF4: a multifunctional nexus connecting tumor progression and immune regulation
Published 2025-02-01“…KLF4 plays a promoter role in tumorigenesis and development, or tumor suppressor as a context-dependent anti- and pro-inflammatory factor. …”
Get full text
Article -
149
miR-559 Inhibits Proliferation, Autophagy, and Angiogenesis of Hepatocellular Carcinoma Cells by Targeting PARD3
Published 2022-01-01“…Although prevention and treatment of HCC has improved, it still faces poor prognosis and high mortality. miRNAs play a critical role in the tumorigenesis of HCC, but the underlying mechanism has not been well investigated. …”
Get full text
Article -
150
Association of pituitary neuroendocrine tumors and neurofibromatosis type 1: assessing causation versus coincidence. Case report
Published 2025-02-01“…NF1 could drive pituitary tumorigenesis via haploinsufficiency, but this hypothesis requires further research. …”
Get full text
Article -
151
Targeting SLITRK4 Restrains Proliferation and Liver Metastasis in Colorectal Cancer via Regulating PI3K/AKT/NFκB Pathway and Tumor‐Associated Macrophage
Published 2025-01-01“…Taken together, these results pinpoint that SLITRK4 regulates CRC tumorigenesis and liver metastasis, and siRNA delivering NPs agents validate the therapeutic potential of targeting SLITRK4 in CRC.…”
Get full text
Article -
152
Recurrent Inflammatory Myofibroblastic Tumor of Larynx Harboring a Novel THBS1::ALK Fusion
Published 2024-01-01“…These findings not only broaden the repertoire of known ALK fusion partners implicated in tumorigenesis but also provide a novel avenue for investigating the etiology of recurrent IMT by considering this fusion event as a causal factor. …”
Get full text
Article -
153
Angiosarcoma Arising in a Patient with a 10-Year-Old Hemangioma
Published 2014-01-01“…The existence of precursor malignancies in the tumorigenesis of sarcomas is still not clearly defined. …”
Get full text
Article -
154
The Metabolic Features of Tumor-Associated Macrophages: Opportunities for Immunotherapy?
Published 2021-01-01“…Within the TME, TAMs exhibit high plasticity and undergo specific functional metabolic alterations according to the availability of tumor tissue oxygen and nutrients, thus further contributing to tumorigenesis and cancer progression. Here, we review the main functional TAM metabolic patterns influenced by TME, including glycolysis, amino acid, and fatty acid metabolism. …”
Get full text
Article -
155
Recent Progress of Genome Study for Anaplastic Thyroid Cancer
Published 2013-06-01“…Although targeted treatment of genetic alterations has emerged as an extremely promising approach to human cancers, such as BRAF in metastatic melanoma, it remains unclear that how commonly genomic alterations are influenced in ATC tumorigenesis. In recent years, genome wide approaches have been exploited to find genetic alterations associated with complex diseases, including cancer. …”
Get full text
Article -
156
Epigenetic Regulations in Neural Stem Cells and Neurological Diseases
Published 2018-01-01“…At the same time, Ten-eleven translocation (Tet) methylcytosine dioxygenases, the rate-limiting enzyme for the 5-hydroxymethylation reaction from 5-methylcytosine to 5-hydroxymethylcytosine, play a critical role in the tumorigenesis and the proliferation and differentiation of stem cells. …”
Get full text
Article -
157
Advances in sodium-glucose transporter protein 2 inhibitors and tumors
Published 2025-02-01“…SGLT2 has been found to be overexpressed in many tumors and involved in tumorigenesis, progression and metastasis, suggesting that SGLT2i has a wide range of applications in tumor therapy. …”
Get full text
Article -
158
Interactions between Myc and Mediators of Inflammation in Chronic Liver Diseases
Published 2015-01-01“…These mediators are the driving force of many inflammatory liver disorders, which often result in fibrosis, cirrhosis, and liver tumorigenesis. c-Myc is involved in many cellular events such as cell growth, proliferation, and differentiation. c-Myc upregulates IL-8, IL-10, TNF-α, and TGF-β, while IL-1, IL-2, IL-4, TNF-α, and TGF-β promote c-Myc expression. …”
Get full text
Article -
159
Suppression of the Oncogenic Transcription Factor FOXM1 by Proteasome Inhibitors
Published 2014-01-01“…The oncogenic transcription factor FOXM1 is one of the key regulators of tumorigenesis. We found that FOXM1 upregulates its own transcription and its protein stability depends on its interaction with the chaperone nucleophosmin. …”
Get full text
Article -
160
Established Principles and Emerging Concepts on the Interplay between Mitochondrial Physiology and S-(De)nitrosylation: Implications in Cancer and Neurodegeneration
Published 2012-01-01“…In this paper we aim at summarizing the current knowledge of mitochondria-related proteins undergoing S-nitrosylation and how this redox modification might impact on mitochondrial functions, whose impairment has been correlated to tumorigenesis and neuronal cell death. In particular, emphasis will be given to the possible, but still neglected implication of denitrosylation reactions in the modulation of mitochondrial SNOs and how they can affect mitochondrion-related cellular process, such as oxidative phosphorylation, mitochondrial dynamics, and mitophagy.…”
Get full text
Article